{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:19:27Z","timestamp":1790421567958,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["1-2001-519"],"award-info":[{"award-number":["1-2001-519"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["0120147B"],"award-info":[{"award-number":["0120147B"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["DAMD17-03-1-0379"],"award-info":[{"award-number":["DAMD17-03-1-0379"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA95004"],"award-info":[{"award-number":["CA95004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY07533"],"award-info":[{"award-number":["EY07533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["DAMD17-02-1-0604"],"award-info":[{"award-number":["DAMD17-02-1-0604"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.exer.2005.09.004","type":"journal-article","created":{"date-parts":[[2005,12,16]],"date-time":"2005-12-16T07:13:23Z","timestamp":1134717203000},"page":"664-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Inhibition of retinal neovascularization by soluble EphA2 receptor"],"prefix":"10.1016","volume":"82","author":[{"given":"Jin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Brantley-Sieders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"McCollum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Qi-Werdich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2005.09.004_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1101\/gad.13.3.295","article-title":"Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial\/venous domains, vascular morphogenesis, and sprouting angiogenesis","volume":"3","author":"Adams","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.exer.2005.09.004_bib2","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.exer.2005.09.004_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bjo.82.5.561","article-title":"VEGF localisation in diabetic retinopathy","volume":"82","author":"Boulton","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.004_bib4","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1038\/sj.onc.1205679","article-title":"Soluble EphA receptors inhibit tumor angiogenesis and progression in vivo","volume":"21","author":"Brantley","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2005.09.004_bib5","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1242\/jcs.01061","article-title":"EphA2 receptor tyrosine kinase regulates endothelial cell migration and assembly through phosphoinositide 3-kinase-mediated rac1 GTPase activation","volume":"117","author":"Brantley-Sieders","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.exer.2005.09.004_bib6","unstructured":"Brantley-Sieders, D.M., Fang, W.B., Hicks, D., Koyama, T., Shyr, Y., Chen, J., in press. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. FASEB J."},{"key":"10.1016\/j.exer.2005.09.004_bib7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1167\/iovs.01-1193","article-title":"Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis","volume":"44","author":"Bullard","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.004_bib8","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell dision","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.004_bib9","first-page":"2","article-title":"Blockade of EphA receptor tyrosine kinase activation inhibits VEGF-induced angiogenesis","volume":"1","author":"Cheng","year":"2002","journal-title":"Mol. Cancer Res. (formerly Cell Growth and Differentiation)"},{"key":"10.1016\/j.exer.2005.09.004_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1476-5586(03)80047-7","article-title":"Inhibition of VEGF-dependent multi-stage carcinogenesis by soluble EphA receptors","volume":"5","author":"Cheng","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.exer.2005.09.004_bib11","first-page":"S73","article-title":"Elk and LERK-2 in developing kidney and microvascular endothelial assembly","volume":"57","author":"Daniel","year":"1996","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.exer.2005.09.004_bib12","first-page":"4574","article-title":"Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis","volume":"59","author":"Daniel","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2005.09.004_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.neuro.21.1.309","article-title":"The ephrins and Eph receptors in neural development","volume":"21","author":"Flanagan","year":"1998","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.exer.2005.09.004_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s004410050927","article-title":"Ephrins and their receptors: a repulsive topic?","volume":"290","author":"Gale","year":"1997","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.exer.2005.09.004_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","article-title":"Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development","volume":"13","author":"Gale","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.exer.2005.09.004_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(00)80276-7","article-title":"Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis","volume":"17","author":"Gale","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.exer.2005.09.004_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1097-2765(00)80342-1","article-title":"Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development","volume":"4","author":"Gerety","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.exer.2005.09.004_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1237","article-title":"Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling","volume":"7","author":"Himanen","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exer.2005.09.004_bib19","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1242\/dev.126.10.2033","article-title":"Eph receptors and ephrins: effectors of morphogenesis","volume":"126","author":"Holder","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.exer.2005.09.004_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiological review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.004_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archopht.1992.01080140123039","article-title":"A new technique for visualization of the human retinal vasculature","volume":"110","author":"Lutty","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.004_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1593\/neo.03457","article-title":"Inhibition of tumor growth and angiogenesis by soluble EphB4","volume":"6","author":"Martiny-Baron","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.exer.2005.09.004_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.exer.2003.12.008","article-title":"Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity","volume":"78","author":"McCollum","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2005.09.004_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0026-2862(87)90021-5","article-title":"Visualization of a developing vasculature","volume":"33","author":"McLeod","year":"1987","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.exer.2005.09.004_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35074604","article-title":"Activation of EphA receptor tyrosine kinase inhibits the ras\/MAPK pathway","volume":"13","author":"Miao","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.exer.2005.09.004_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K","article-title":"Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy","volume":"13","author":"Miller","year":"1997","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.exer.2005.09.004_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.exer.2005.09.004_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jemt.10177","article-title":"Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis","volume":"59","author":"Nakamoto","year":"2002","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.exer.2005.09.004_bib29","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/sj.onc.1204004","article-title":"The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization","volume":"19","author":"Ogawa","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2005.09.004_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1126\/science.7536959","article-title":"Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-a-induced angiogenesis","volume":"268","author":"Pandey","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.exer.2005.09.004_bib31","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1167\/iovs.02-0804","article-title":"Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity","volume":"44","author":"Penn","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.004_bib32","first-page":"2063","article-title":"The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats","volume":"36","author":"Penn","year":"1995","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.004_bib33","first-page":"283","article-title":"The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity","volume":"42","author":"Penn","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.004_bib34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.exer.2005.09.004_bib35","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1073\/pnas.040378497","article-title":"Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization","volume":"97","author":"Pozzi","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.exer.2005.09.004_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08977199709021522","article-title":"Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina","volume":"14","author":"Robbins","year":"1997","journal-title":"Growth Factor"},{"key":"10.1016\/j.exer.2005.09.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977199809017487","article-title":"Evidence for upregulation and redistribution of vascular endothelial growth factor receptors flt-1 and flk-1 in the oxygen-injured rat retina","volume":"16","author":"Robbins","year":"1998","journal-title":"Growth Factors"},{"key":"10.1016\/j.exer.2005.09.004_bib38","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.93.10.4851","article-title":"Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy","volume":"93","author":"Robinson","year":"1996","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.exer.2005.09.004_bib39","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.onc.1201380","article-title":"p38 MAP kinase activation by vasclar endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells","volume":"15","author":"Rousseau","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2005.09.004_bib40","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1074\/jbc.275.14.10661","article-title":"Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2\/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase","volume":"275","author":"Rousseau","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2005.09.004_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0925-4773(94)90078-7","article-title":"The expression of the receptor tyrosine kinase, eck, is highly restricted during early mouse development","volume":"46","author":"Ruiz","year":"1994","journal-title":"Mech. Dev."},{"key":"10.1016\/j.exer.2005.09.004_bib42","first-page":"1075","article-title":"Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells","volume":"36","author":"Sakamoto","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2005.09.004_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/dbio.2000.9957","article-title":"Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization","volume":"230","author":"Shin","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.exer.2005.09.004_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/14728214.8.1.239","article-title":"Pharmacologic therapy for diabetic retinopathy","volume":"8","author":"Speicher","year":"2003","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.exer.2005.09.004_bib45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0898-6568(03)00072-X","article-title":"Role of ephrin B2 in human retinal endothelial cell proliferation and migration","volume":"15","author":"Steinle","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exer.2005.09.004_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajo.2004.04.006","article-title":"Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases","volume":"138","author":"Umeda","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2005.09.004_bib47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0092-8674(00)81436-1","article-title":"Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4","volume":"93","author":"Wang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exer.2005.09.004_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exer.2005.09.004_bib49","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1167\/iovs.04-0983","article-title":"Soluble forms of ephrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy","volume":"46","author":"Zamora","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483505002939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483505002939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:17:25Z","timestamp":1778635045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483505002939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0014483505002939"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2005.09.004","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of retinal neovascularization by soluble EphA2 receptor","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2005.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}